Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Thromboresistant semi-IPN hydrogel coating: Towards improvement of the hemocompatibility/biocompatibility of metallic stent implants.

Obiweluozor FO, Tiwari AP, Lee JH, Batgerel T, Kim JY, Lee D, Park CH, Kim CS.

Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:1274-1288. doi: 10.1016/j.msec.2019.02.054. Epub 2019 Feb 20.

PMID:
30889662
2.

Thromboresistant and endothelialization effects of dopamine-mediated heparin coating on a stent material surface.

Bae IH, Park IK, Park DS, Lee H, Jeong MH.

J Mater Sci Mater Med. 2012 May;23(5):1259-69. doi: 10.1007/s10856-012-4587-5. Epub 2012 Mar 3.

PMID:
22389099
3.

Angioplasty.

Zain MA, Siddiqui WJ.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Jan 24.

4.

The effect of REDV/TiO2 coating coronary stents on in-stent restenosis and re-endothelialization.

Xu X, Wang L, Wang G, Jin Y.

J Biomater Appl. 2017 Jan;31(6):911-922. doi: 10.1177/0885328216675829. Epub 2016 Nov 10.

PMID:
30208804
5.

Elastin-like recombinamer-covered stents: Towards a fully biocompatible and non-thrombogenic device for cardiovascular diseases.

de Torre IG, Wolf F, Santos M, Rongen L, Alonso M, Jockenhoevel S, Rodríguez-Cabello JC, Mela P.

Acta Biomater. 2015 Jan;12:146-155. doi: 10.1016/j.actbio.2014.10.029. Epub 2014 Oct 29.

PMID:
25448343
6.

Starch-based semi-IPN hydrogel nanocomposite integrated with clinoptilolite: Preparation and swelling kinetic study.

Olad A, Doustdar F, Gharekhani H.

Carbohydr Polym. 2018 Nov 15;200:516-528. doi: 10.1016/j.carbpol.2018.08.014. Epub 2018 Aug 7.

PMID:
30177193
7.

Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis.

Lih E, Choi SG, Ahn DJ, Joung YK, Han DK.

J Tissue Eng. 2016 Dec 17;7:2041731416683745. doi: 10.1177/2041731416683745. eCollection 2016 Jan-Dec.

8.

Immobilization of nano Cu-MOFs with polydopamine coating for adaptable gasotransmitter generation and copper ion delivery on cardiovascular stents.

Fan Y, Zhang Y, Zhao Q, Xie Y, Luo R, Yang P, Weng Y.

Biomaterials. 2019 Jun;204:36-45. doi: 10.1016/j.biomaterials.2019.03.007. Epub 2019 Mar 9.

PMID:
30875517
9.

In vitro investigation of enhanced hemocompatibility and endothelial cell proliferation associated with quinone-rich polydopamine coating.

Luo R, Tang L, Zhong S, Yang Z, Wang J, Weng Y, Tu Q, Jiang C, Huang N.

ACS Appl Mater Interfaces. 2013 Mar 13;5(5):1704-14. doi: 10.1021/am3027635. Epub 2013 Feb 19.

PMID:
23384031
10.

The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model.

Bae IH, Jeong MH, Kim JH, Park YH, Lim KS, Park DS, Shim JW, Kim JH, Ahn Y, Hong YJ, Sim DS.

Korean Circ J. 2017 Jan;47(1):123-131. doi: 10.4070/kcj.2016.0203. Epub 2016 Dec 23.

11.

Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries.

Sperling C, Waliszewski MW, Kherad B, Krackhardt F.

Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719826335. doi: 10.1177/1753944719826335.

12.

New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets.

Busch R, Strohbach A, Rethfeldt S, Walz S, Busch M, Petersen S, Felix S, Sternberg K.

Acta Biomater. 2014 Feb;10(2):688-700. doi: 10.1016/j.actbio.2013.10.015. Epub 2013 Oct 19.

PMID:
24148751
13.
14.

Drug-eluting stents.

García-García HM, Vaina S, Tsuchida K, Serruys PW.

Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319. Review.

PMID:
17091802
15.

Development of collagen/polydopamine complexed matrix as mechanically enhanced and highly biocompatible semi-natural tissue engineering scaffold.

Hu Y, Dan W, Xiong S, Kang Y, Dhinakar A, Wu J, Gu Z.

Acta Biomater. 2017 Jan 1;47:135-148. doi: 10.1016/j.actbio.2016.10.017. Epub 2016 Oct 12.

PMID:
27744068
16.

Advances in coronary stent technology--active drug-loaded stent surfaces for prevention of restenosis and improvement of biocompatibility.

Sternberg K, Grabow N, Petersen S, Weitschies W, Harder C, Ince H, Kroemer HK, Schmitz KP.

Curr Pharm Biotechnol. 2013;14(1):76-90. Review.

PMID:
23092260
17.

In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.

Lin Q, Ding X, Qiu F, Song X, Fu G, Ji J.

Biomaterials. 2010 May;31(14):4017-25. doi: 10.1016/j.biomaterials.2010.01.092. Epub 2010 Feb 9.

PMID:
20149438
18.

In vitro and in vivo evaluation of a dextran-graft-polybutylmethacrylate copolymer coated on CoCr metallic stent.

Delattre C, Velazquez D, Roques C, Pavon-Djavid G, Ollivier V, Lokajczyk A, Avramoglou T, Gueguen V, Louedec L, Caligiuri G, Jandrot-Perrus M, Boisson-Vidal C, Letourneur D, Meddahi-Pelle A.

Bioimpacts. 2019;9(1):25-36. doi: 10.15171/bi.2019.04. Epub 2018 Oct 2.

19.

Coronary Stents.

Zain MA, Siddiqui WJ.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Jan 24.

20.

Supplemental Content

Support Center